Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF4 | hg19_v2_chr9_-_110251836_110251927 | 0.63 | 1.1e-04 | Click! |
PATZ1 | hg19_v2_chr22_-_31741757_31741770 | 0.06 | 7.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_22457100 | 13.59 |
ENST00000409586.3
|
C8orf58
|
chromosome 8 open reading frame 58 |
chr18_+_77155856 | 11.50 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr8_+_22457127 | 11.27 |
ENST00000289989.5
|
C8orf58
|
chromosome 8 open reading frame 58 |
chr18_+_77155942 | 11.00 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr2_-_37899323 | 10.55 |
ENST00000295324.3
ENST00000457889.1 |
CDC42EP3
|
CDC42 effector protein (Rho GTPase binding) 3 |
chr19_-_39226045 | 10.37 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
chr4_+_154387480 | 10.18 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
chr11_-_64512469 | 9.45 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr6_-_30654977 | 9.16 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr20_+_42295745 | 8.97 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr11_-_64511789 | 8.90 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr2_+_238600788 | 8.71 |
ENST00000289175.6
ENST00000244815.5 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
chr7_-_102252038 | 8.66 |
ENST00000461209.1
|
RASA4
|
RAS p21 protein activator 4 |
chr22_-_50746027 | 8.54 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
chr11_+_2466218 | 8.49 |
ENST00000155840.5
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1 |
chr22_-_43583079 | 8.40 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr18_+_11981547 | 8.11 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr18_+_11981427 | 8.09 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr19_-_44172396 | 8.05 |
ENST00000602141.1
ENST00000593939.1 ENST00000599546.1 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr2_+_10183651 | 8.03 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
chr3_-_185542761 | 7.96 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr2_-_197036289 | 7.85 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chr21_+_44394742 | 7.85 |
ENST00000432907.2
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
chr8_-_144651024 | 7.82 |
ENST00000524906.1
ENST00000532862.1 ENST00000534459.1 |
MROH6
|
maestro heat-like repeat family member 6 |
chr19_-_1652575 | 7.70 |
ENST00000587235.1
ENST00000262965.5 |
TCF3
|
transcription factor 3 |
chr12_+_57916466 | 7.70 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
chr19_+_16435625 | 7.69 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr19_+_54372877 | 7.68 |
ENST00000414489.1
|
MYADM
|
myeloid-associated differentiation marker |
chr7_+_97910962 | 7.64 |
ENST00000539286.1
|
BRI3
|
brain protein I3 |
chr19_-_44172467 | 7.61 |
ENST00000599892.1
|
PLAUR
|
plasminogen activator, urokinase receptor |
chr2_+_11295498 | 7.60 |
ENST00000295083.3
ENST00000441908.2 |
PQLC3
|
PQ loop repeat containing 3 |
chrX_-_153599578 | 7.57 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr3_-_185542817 | 7.53 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_+_74833518 | 7.52 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr16_+_29817841 | 7.51 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr8_+_1711918 | 7.48 |
ENST00000331222.4
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
chr9_+_140500087 | 7.44 |
ENST00000371421.4
|
ARRDC1
|
arrestin domain containing 1 |
chr18_+_77160282 | 7.40 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr7_-_149470540 | 7.39 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
chr14_+_105953204 | 7.39 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr9_-_110251836 | 7.29 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr19_+_54371114 | 7.24 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
chr11_-_64512273 | 7.20 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr14_-_92302825 | 7.15 |
ENST00000556018.1
|
TC2N
|
tandem C2 domains, nuclear |
chr3_+_53195517 | 7.11 |
ENST00000487897.1
|
PRKCD
|
protein kinase C, delta |
chr2_+_11295624 | 7.06 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
chr10_-_135090338 | 7.03 |
ENST00000415217.3
|
ADAM8
|
ADAM metallopeptidase domain 8 |
chr8_-_142318398 | 6.96 |
ENST00000520137.1
|
SLC45A4
|
solute carrier family 45, member 4 |
chr12_+_105724613 | 6.95 |
ENST00000549934.2
|
C12orf75
|
chromosome 12 open reading frame 75 |
chr1_-_38471156 | 6.90 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
chr9_-_35650900 | 6.88 |
ENST00000259608.3
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1 |
chr19_-_6767516 | 6.86 |
ENST00000245908.6
|
SH2D3A
|
SH2 domain containing 3A |
chr4_-_1166954 | 6.84 |
ENST00000514490.1
ENST00000431380.1 ENST00000503765.1 |
SPON2
|
spondin 2, extracellular matrix protein |
chr2_+_112812778 | 6.78 |
ENST00000283206.4
|
TMEM87B
|
transmembrane protein 87B |
chr19_+_35645817 | 6.75 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr17_-_80291818 | 6.74 |
ENST00000269389.3
ENST00000581691.1 |
SECTM1
|
secreted and transmembrane 1 |
chr6_-_32157947 | 6.74 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr18_+_11981014 | 6.67 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr10_-_135090360 | 6.65 |
ENST00000486609.1
ENST00000445355.3 ENST00000485491.2 |
ADAM8
|
ADAM metallopeptidase domain 8 |
chr7_+_97910981 | 6.57 |
ENST00000297290.3
|
BRI3
|
brain protein I3 |
chr14_+_105953246 | 6.56 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr19_+_35645618 | 6.50 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr16_+_29817399 | 6.49 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr18_+_3449821 | 6.46 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
chr19_-_11450249 | 6.45 |
ENST00000222120.3
|
RAB3D
|
RAB3D, member RAS oncogene family |
chr17_-_73840415 | 6.45 |
ENST00000592386.1
ENST00000412096.2 ENST00000586147.1 |
UNC13D
|
unc-13 homolog D (C. elegans) |
chr11_-_68519026 | 6.43 |
ENST00000255087.5
|
MTL5
|
metallothionein-like 5, testis-specific (tesmin) |
chr20_-_62711259 | 6.38 |
ENST00000332298.5
|
RGS19
|
regulator of G-protein signaling 19 |
chr12_+_57916584 | 6.37 |
ENST00000546632.1
ENST00000549623.1 ENST00000431731.2 |
MBD6
|
methyl-CpG binding domain protein 6 |
chr1_-_3528034 | 6.35 |
ENST00000356575.4
|
MEGF6
|
multiple EGF-like-domains 6 |
chr17_-_73840614 | 6.33 |
ENST00000586108.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
chr16_+_66638567 | 6.31 |
ENST00000567572.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chrX_+_152990302 | 6.31 |
ENST00000218104.3
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1 |
chr1_-_111746966 | 6.25 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
chr16_+_66638616 | 6.22 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr1_-_1141927 | 6.20 |
ENST00000328596.6
ENST00000379265.5 |
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr11_-_560703 | 6.18 |
ENST00000441853.1
ENST00000329451.3 |
C11orf35
|
chromosome 11 open reading frame 35 |
chr22_-_50746001 | 6.12 |
ENST00000359337.4
|
PLXNB2
|
plexin B2 |
chr14_-_91884150 | 6.11 |
ENST00000553403.1
|
CCDC88C
|
coiled-coil domain containing 88C |
chr14_-_91884115 | 6.06 |
ENST00000389857.6
|
CCDC88C
|
coiled-coil domain containing 88C |
chr17_-_61777459 | 6.06 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
chr7_-_105925558 | 6.03 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr1_+_226250379 | 6.01 |
ENST00000366815.3
ENST00000366814.3 |
H3F3A
|
H3 histone, family 3A |
chr19_-_913160 | 6.00 |
ENST00000361574.5
ENST00000587975.1 |
R3HDM4
|
R3H domain containing 4 |
chr19_-_51875523 | 5.99 |
ENST00000593572.1
ENST00000595157.1 |
NKG7
|
natural killer cell group 7 sequence |
chr14_-_92302784 | 5.99 |
ENST00000340892.5
ENST00000360594.5 |
TC2N
|
tandem C2 domains, nuclear |
chr20_-_62710832 | 5.99 |
ENST00000395042.1
|
RGS19
|
regulator of G-protein signaling 19 |
chr20_-_52210368 | 5.96 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
chr17_+_81037473 | 5.95 |
ENST00000320095.7
|
METRNL
|
meteorin, glial cell differentiation regulator-like |
chrX_+_118892545 | 5.94 |
ENST00000343905.3
|
SOWAHD
|
sosondowah ankyrin repeat domain family member D |
chr19_-_51875894 | 5.93 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr14_-_96180435 | 5.92 |
ENST00000556450.1
ENST00000555202.1 ENST00000554012.1 ENST00000402399.1 |
TCL1A
|
T-cell leukemia/lymphoma 1A |
chr22_-_50970506 | 5.87 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr10_-_126849588 | 5.87 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
chr19_+_46010674 | 5.83 |
ENST00000245932.6
ENST00000592139.1 ENST00000590603.1 |
VASP
|
vasodilator-stimulated phosphoprotein |
chr12_-_58240470 | 5.83 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
chrX_-_135056106 | 5.82 |
ENST00000433339.2
|
MMGT1
|
membrane magnesium transporter 1 |
chr4_-_1166623 | 5.78 |
ENST00000290902.5
|
SPON2
|
spondin 2, extracellular matrix protein |
chr9_+_140500126 | 5.72 |
ENST00000431925.2
ENST00000419386.1 |
ARRDC1
|
arrestin domain containing 1 |
chr2_+_192542879 | 5.70 |
ENST00000409510.1
|
NABP1
|
nucleic acid binding protein 1 |
chr22_+_45064593 | 5.68 |
ENST00000432186.1
|
PRR5
|
proline rich 5 (renal) |
chr17_-_80275417 | 5.68 |
ENST00000583376.1
ENST00000578509.1 ENST00000584284.1 ENST00000582480.1 |
CD7
|
CD7 molecule |
chr22_+_22735135 | 5.66 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr19_+_54372693 | 5.65 |
ENST00000391768.2
|
MYADM
|
myeloid-associated differentiation marker |
chr2_+_192543153 | 5.57 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
chr1_-_200992827 | 5.56 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
chr1_-_1142067 | 5.54 |
ENST00000379268.2
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr11_-_6677018 | 5.50 |
ENST00000299441.3
|
DCHS1
|
dachsous cadherin-related 1 |
chr2_+_219264762 | 5.50 |
ENST00000452977.1
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
chr10_+_104155450 | 5.50 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr18_+_3449695 | 5.49 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr1_+_43148625 | 5.48 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
chr22_-_42322795 | 5.47 |
ENST00000291232.3
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C |
chr20_+_62371206 | 5.46 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
chr2_-_174828892 | 5.45 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
chr11_-_67771513 | 5.44 |
ENST00000227471.2
|
UNC93B1
|
unc-93 homolog B1 (C. elegans) |
chr7_-_149470297 | 5.41 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
chr19_-_14201776 | 5.41 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr16_+_66638685 | 5.39 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr13_-_114898016 | 5.37 |
ENST00000542651.1
ENST00000334062.7 |
RASA3
|
RAS p21 protein activator 3 |
chr5_-_180237445 | 5.35 |
ENST00000393340.3
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr10_-_126849068 | 5.33 |
ENST00000494626.2
ENST00000337195.5 |
CTBP2
|
C-terminal binding protein 2 |
chr2_+_74212073 | 5.32 |
ENST00000441217.1
|
AC073046.25
|
AC073046.25 |
chr12_+_58148842 | 5.30 |
ENST00000266643.5
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9 |
chr16_-_8962853 | 5.30 |
ENST00000565287.1
ENST00000311052.5 |
CARHSP1
|
calcium regulated heat stable protein 1, 24kDa |
chr19_-_18632861 | 5.29 |
ENST00000262809.4
|
ELL
|
elongation factor RNA polymerase II |
chr5_+_40679584 | 5.28 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chr11_+_1889880 | 5.27 |
ENST00000405957.2
|
LSP1
|
lymphocyte-specific protein 1 |
chr13_-_74708372 | 5.27 |
ENST00000377666.4
|
KLF12
|
Kruppel-like factor 12 |
chr15_+_65134088 | 5.27 |
ENST00000323544.4
ENST00000437723.1 |
PLEKHO2
AC069368.3
|
pleckstrin homology domain containing, family O member 2 Uncharacterized protein |
chr12_-_48298785 | 5.26 |
ENST00000550325.1
ENST00000546653.1 ENST00000549336.1 ENST00000535672.1 ENST00000229022.3 ENST00000548664.1 |
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor |
chr21_+_44394620 | 5.25 |
ENST00000291547.5
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
chr8_-_99837856 | 5.24 |
ENST00000518165.1
ENST00000419617.2 |
STK3
|
serine/threonine kinase 3 |
chr12_+_65004292 | 5.23 |
ENST00000542104.1
ENST00000336061.2 |
RASSF3
|
Ras association (RalGDS/AF-6) domain family member 3 |
chr11_-_46142948 | 5.22 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
chr12_+_54378923 | 5.22 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
chr19_-_4065730 | 5.21 |
ENST00000601588.1
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
chr9_-_139891165 | 5.20 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
chr6_+_144471643 | 5.20 |
ENST00000367568.4
|
STX11
|
syntaxin 11 |
chr16_-_89268070 | 5.20 |
ENST00000562855.2
|
SLC22A31
|
solute carrier family 22, member 31 |
chr12_-_54694807 | 5.19 |
ENST00000435572.2
|
NFE2
|
nuclear factor, erythroid 2 |
chr7_+_2559399 | 5.18 |
ENST00000222725.5
ENST00000359574.3 |
LFNG
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr17_-_73840774 | 5.17 |
ENST00000207549.4
|
UNC13D
|
unc-13 homolog D (C. elegans) |
chr11_+_67056867 | 5.16 |
ENST00000514166.1
|
ANKRD13D
|
ankyrin repeat domain 13 family, member D |
chr22_+_22676808 | 5.15 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr1_+_154975110 | 5.15 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
chr19_-_2015699 | 5.14 |
ENST00000255608.4
|
BTBD2
|
BTB (POZ) domain containing 2 |
chr8_-_37756972 | 5.13 |
ENST00000330843.4
ENST00000522727.1 ENST00000287263.4 |
RAB11FIP1
|
RAB11 family interacting protein 1 (class I) |
chr19_+_46009837 | 5.09 |
ENST00000589627.1
|
VASP
|
vasodilator-stimulated phosphoprotein |
chr8_-_143833918 | 5.06 |
ENST00000359228.3
|
LYPD2
|
LY6/PLAUR domain containing 2 |
chr19_-_2051223 | 5.04 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr2_+_109150850 | 5.02 |
ENST00000544547.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr14_-_105487381 | 5.01 |
ENST00000392590.3
ENST00000336219.3 |
CDCA4
|
cell division cycle associated 4 |
chr1_-_115632035 | 5.00 |
ENST00000433172.1
ENST00000369514.2 ENST00000369516.2 ENST00000369515.2 |
TSPAN2
|
tetraspanin 2 |
chr16_-_431936 | 4.98 |
ENST00000250930.3
ENST00000431232.2 |
TMEM8A
|
transmembrane protein 8A |
chrX_-_153191708 | 4.96 |
ENST00000393721.1
ENST00000370028.3 |
ARHGAP4
|
Rho GTPase activating protein 4 |
chrY_+_22737604 | 4.94 |
ENST00000361365.2
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr22_+_45098067 | 4.91 |
ENST00000336985.6
ENST00000403696.1 ENST00000457960.1 ENST00000361473.5 |
PRR5
PRR5-ARHGAP8
|
proline rich 5 (renal) PRR5-ARHGAP8 readthrough |
chr7_+_98972298 | 4.91 |
ENST00000252725.5
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr19_-_47734448 | 4.90 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr1_-_153517473 | 4.87 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
chr10_+_135192782 | 4.87 |
ENST00000480071.2
|
PAOX
|
polyamine oxidase (exo-N4-amino) |
chr8_-_101734308 | 4.85 |
ENST00000519004.1
ENST00000519363.1 ENST00000520142.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
chr7_-_128045984 | 4.85 |
ENST00000470772.1
ENST00000480861.1 ENST00000496200.1 |
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
chr1_+_118148556 | 4.85 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
chr15_-_60690163 | 4.84 |
ENST00000558998.1
ENST00000560165.1 ENST00000557986.1 ENST00000559780.1 ENST00000559467.1 ENST00000559956.1 ENST00000332680.4 ENST00000396024.3 ENST00000421017.2 ENST00000560466.1 ENST00000558132.1 ENST00000559113.1 ENST00000557906.1 ENST00000558558.1 ENST00000560468.1 ENST00000559370.1 ENST00000558169.1 ENST00000559725.1 ENST00000558985.1 ENST00000451270.2 |
ANXA2
|
annexin A2 |
chr9_-_130517522 | 4.82 |
ENST00000373274.3
ENST00000420366.1 |
SH2D3C
|
SH2 domain containing 3C |
chr19_+_1071203 | 4.81 |
ENST00000543365.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr17_-_76124711 | 4.81 |
ENST00000306591.7
ENST00000590602.1 |
TMC6
|
transmembrane channel-like 6 |
chr14_-_21566731 | 4.80 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
chr7_+_43622664 | 4.80 |
ENST00000319357.5
|
STK17A
|
serine/threonine kinase 17a |
chr19_-_6767431 | 4.79 |
ENST00000437152.3
ENST00000597687.1 |
SH2D3A
|
SH2 domain containing 3A |
chr7_-_102158157 | 4.77 |
ENST00000541662.1
ENST00000306682.6 ENST00000465829.1 |
RASA4B
|
RAS p21 protein activator 4B |
chr12_-_120703523 | 4.77 |
ENST00000267257.7
ENST00000228307.7 ENST00000424649.2 |
PXN
|
paxillin |
chrX_-_135056216 | 4.75 |
ENST00000305963.2
|
MMGT1
|
membrane magnesium transporter 1 |
chr22_+_50624323 | 4.72 |
ENST00000380909.4
ENST00000303434.4 |
TRABD
|
TraB domain containing |
chr17_+_75277492 | 4.70 |
ENST00000427177.1
ENST00000591198.1 |
SEPT9
|
septin 9 |
chr2_-_235405679 | 4.69 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr17_-_62207485 | 4.68 |
ENST00000433197.3
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1 |
chr8_+_128747757 | 4.67 |
ENST00000517291.1
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr2_-_61697862 | 4.67 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
chr5_+_118604385 | 4.65 |
ENST00000274456.6
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr15_+_63569785 | 4.65 |
ENST00000380343.4
ENST00000560353.1 |
APH1B
|
APH1B gamma secretase subunit |
chr17_-_38721711 | 4.64 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr19_+_1941117 | 4.64 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr19_+_41869894 | 4.64 |
ENST00000413014.2
|
TMEM91
|
transmembrane protein 91 |
chr16_+_88519669 | 4.62 |
ENST00000319555.3
|
ZFPM1
|
zinc finger protein, FOG family member 1 |
chr19_-_2050852 | 4.61 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr4_+_1723512 | 4.61 |
ENST00000493975.1
|
TACC3
|
transforming, acidic coiled-coil containing protein 3 |
chr16_+_50280020 | 4.60 |
ENST00000564965.1
|
ADCY7
|
adenylate cyclase 7 |
chr4_+_2794785 | 4.59 |
ENST00000503219.1
|
SH3BP2
|
SH3-domain binding protein 2 |
chr2_+_238600933 | 4.59 |
ENST00000420665.1
ENST00000392000.4 |
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1 |
chr10_+_135192695 | 4.58 |
ENST00000368539.4
ENST00000278060.5 ENST00000357296.3 |
PAOX
|
polyamine oxidase (exo-N4-amino) |
chr22_-_36784035 | 4.56 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chr14_+_103058948 | 4.55 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr5_-_180229833 | 4.55 |
ENST00000307826.4
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr5_-_176936817 | 4.55 |
ENST00000502885.1
ENST00000506493.1 |
DOK3
|
docking protein 3 |
chr5_+_95998673 | 4.55 |
ENST00000514845.1
|
CAST
|
calpastatin |
chr16_+_3096638 | 4.54 |
ENST00000336577.4
|
MMP25
|
matrix metallopeptidase 25 |
chr1_-_3447967 | 4.54 |
ENST00000294599.4
|
MEGF6
|
multiple EGF-like-domains 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 21.2 | GO:0002432 | granuloma formation(GO:0002432) |
4.9 | 14.6 | GO:0003192 | mitral valve formation(GO:0003192) |
4.6 | 13.7 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
4.3 | 13.0 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
3.9 | 11.7 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
3.7 | 14.6 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
3.6 | 10.9 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
3.6 | 28.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.5 | 10.4 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
3.3 | 20.0 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
3.3 | 16.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
3.2 | 9.6 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
3.2 | 22.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
3.0 | 6.0 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
3.0 | 11.9 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
3.0 | 23.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
3.0 | 8.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
2.9 | 14.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.9 | 8.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
2.8 | 11.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
2.7 | 5.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
2.7 | 24.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
2.4 | 7.3 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
2.4 | 9.7 | GO:0009447 | putrescine catabolic process(GO:0009447) |
2.4 | 7.1 | GO:0043181 | vacuolar sequestering(GO:0043181) |
2.3 | 11.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.3 | 11.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
2.2 | 20.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
2.2 | 6.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.2 | 15.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
2.1 | 2.1 | GO:0060157 | urinary bladder development(GO:0060157) |
2.0 | 2.0 | GO:2001074 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
2.0 | 2.0 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
2.0 | 8.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
2.0 | 6.0 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
2.0 | 9.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
2.0 | 2.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
2.0 | 5.9 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
1.9 | 9.6 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
1.9 | 7.6 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
1.9 | 7.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.9 | 5.6 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
1.8 | 7.2 | GO:0044145 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
1.8 | 1.8 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
1.8 | 9.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.8 | 3.6 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
1.8 | 5.4 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
1.8 | 5.3 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
1.7 | 8.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.7 | 8.7 | GO:0060374 | mast cell differentiation(GO:0060374) |
1.7 | 15.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.7 | 25.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.7 | 6.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.7 | 8.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.7 | 5.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
1.7 | 8.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.7 | 5.0 | GO:1901656 | glycoside transport(GO:1901656) |
1.7 | 5.0 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
1.7 | 8.3 | GO:0032796 | uropod organization(GO:0032796) |
1.7 | 28.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.7 | 6.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.6 | 1.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
1.6 | 8.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.6 | 4.9 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
1.6 | 4.9 | GO:0061485 | memory T cell proliferation(GO:0061485) |
1.6 | 1.6 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
1.6 | 6.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.6 | 4.8 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
1.6 | 4.8 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
1.6 | 7.9 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
1.6 | 1.6 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.6 | 4.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
1.6 | 1.6 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.6 | 3.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.6 | 6.2 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
1.6 | 7.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.5 | 15.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.5 | 3.1 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.5 | 1.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
1.5 | 9.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
1.5 | 4.6 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.5 | 1.5 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
1.5 | 7.5 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
1.5 | 3.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
1.5 | 3.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.5 | 4.5 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.5 | 3.0 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.5 | 3.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.5 | 7.3 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.5 | 27.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.5 | 4.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
1.4 | 8.7 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
1.4 | 12.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.4 | 4.2 | GO:0002339 | B cell selection(GO:0002339) |
1.4 | 18.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.4 | 7.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.4 | 4.2 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
1.4 | 16.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.4 | 15.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.4 | 15.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.4 | 2.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.4 | 4.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
1.4 | 1.4 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
1.4 | 13.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
1.4 | 10.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.4 | 5.4 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
1.4 | 9.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.3 | 6.7 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.3 | 8.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.3 | 1.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.3 | 5.3 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
1.3 | 2.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.3 | 5.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.3 | 15.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.3 | 7.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
1.3 | 5.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
1.3 | 3.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.3 | 1.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
1.3 | 7.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.3 | 1.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.3 | 10.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.3 | 3.9 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.3 | 10.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.3 | 5.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
1.3 | 3.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
1.3 | 1.3 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
1.3 | 6.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.3 | 8.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.3 | 17.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.2 | 1.2 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
1.2 | 3.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.2 | 1.2 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
1.2 | 4.9 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.2 | 11.1 | GO:0046836 | glycolipid transport(GO:0046836) |
1.2 | 16.1 | GO:0046449 | creatinine metabolic process(GO:0046449) |
1.2 | 3.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
1.2 | 1.2 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
1.2 | 13.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.2 | 3.7 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
1.2 | 1.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.2 | 1.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.2 | 2.4 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
1.2 | 3.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.2 | 3.6 | GO:0052510 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
1.2 | 18.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.2 | 4.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.2 | 8.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.2 | 3.6 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
1.2 | 10.8 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
1.2 | 8.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
1.2 | 4.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.2 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.2 | 5.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.2 | 1.2 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
1.2 | 3.5 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
1.2 | 4.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.2 | 3.5 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
1.2 | 8.2 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
1.2 | 17.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.2 | 1.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
1.2 | 4.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.2 | 2.3 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
1.2 | 1.2 | GO:0097338 | response to clozapine(GO:0097338) |
1.1 | 5.7 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.1 | 5.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
1.1 | 5.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.1 | 3.4 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
1.1 | 5.7 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
1.1 | 9.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
1.1 | 3.4 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
1.1 | 1.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
1.1 | 2.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.1 | 5.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.1 | 4.5 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.1 | 7.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.1 | 6.7 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
1.1 | 3.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
1.1 | 6.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.1 | 2.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
1.1 | 15.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.1 | 3.3 | GO:2000563 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
1.1 | 15.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
1.1 | 3.3 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
1.1 | 16.5 | GO:0060613 | fat pad development(GO:0060613) |
1.1 | 3.3 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.1 | 5.4 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
1.1 | 5.4 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
1.1 | 4.3 | GO:2000173 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.1 | 6.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
1.1 | 2.2 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
1.1 | 4.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
1.1 | 3.2 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
1.1 | 3.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.1 | 3.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
1.1 | 1.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.1 | 2.1 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
1.1 | 8.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.1 | 9.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.1 | 5.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.0 | 8.3 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
1.0 | 3.1 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
1.0 | 5.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
1.0 | 14.5 | GO:0044351 | macropinocytosis(GO:0044351) |
1.0 | 2.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.0 | 1.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.0 | 1.0 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
1.0 | 7.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.0 | 5.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
1.0 | 1.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
1.0 | 1.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
1.0 | 3.1 | GO:0045556 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
1.0 | 1.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
1.0 | 5.1 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.0 | 5.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
1.0 | 3.0 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
1.0 | 7.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.0 | 7.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.0 | 14.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.0 | 3.0 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
1.0 | 1.0 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
1.0 | 4.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.0 | 13.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.0 | 2.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.0 | 3.0 | GO:0072535 | tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
1.0 | 5.0 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.0 | 5.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.0 | 4.9 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.0 | 5.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
1.0 | 1.0 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
1.0 | 5.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.0 | 2.9 | GO:1902103 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
1.0 | 3.9 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
1.0 | 17.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.0 | 1.0 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
1.0 | 4.9 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
1.0 | 2.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.0 | 5.8 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
1.0 | 1.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.0 | 1.0 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
1.0 | 3.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
1.0 | 1.9 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
1.0 | 2.9 | GO:0002818 | intracellular defense response(GO:0002818) |
1.0 | 1.0 | GO:0060266 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.0 | 5.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.0 | 13.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 6.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
1.0 | 4.8 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
1.0 | 2.9 | GO:0009405 | pathogenesis(GO:0009405) |
1.0 | 1.9 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.9 | 14.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.9 | 1.9 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.9 | 3.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.9 | 8.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.9 | 4.7 | GO:0015862 | uridine transport(GO:0015862) |
0.9 | 8.5 | GO:0030220 | platelet formation(GO:0030220) |
0.9 | 3.8 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.9 | 13.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.9 | 9.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 3.7 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.9 | 3.7 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.9 | 8.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.9 | 1.9 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.9 | 4.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.9 | 2.8 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.9 | 1.9 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.9 | 0.9 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.9 | 5.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.9 | 5.5 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.9 | 1.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.9 | 5.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.9 | 1.8 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.9 | 3.7 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.9 | 5.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.9 | 3.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.9 | 2.7 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.9 | 1.8 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.9 | 3.6 | GO:1905044 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.9 | 3.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.9 | 1.8 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.9 | 1.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.9 | 9.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.9 | 1.8 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.9 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.9 | 3.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.9 | 2.7 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.9 | 2.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.9 | 2.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.9 | 2.7 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.9 | 6.2 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.9 | 10.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.9 | 0.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.9 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.9 | 30.9 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.9 | 31.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.9 | 7.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.9 | 6.2 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.9 | 3.5 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.9 | 6.1 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.9 | 8.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.9 | 1.7 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.9 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.9 | 2.6 | GO:0035283 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.9 | 3.5 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.9 | 1.7 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.9 | 2.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.9 | 1.7 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.9 | 7.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.9 | 1.7 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.9 | 8.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.9 | 1.7 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.9 | 0.9 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.8 | 0.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.8 | 5.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 1.7 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.8 | 3.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.8 | 3.3 | GO:0042113 | B cell activation(GO:0042113) |
0.8 | 4.2 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.8 | 9.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.8 | 2.5 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.8 | 5.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.8 | 2.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.8 | 0.8 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.8 | 4.9 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.8 | 0.8 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.8 | 4.1 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.8 | 10.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 0.8 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.8 | 3.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.8 | 2.5 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.8 | 8.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 3.3 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.8 | 2.4 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.8 | 0.8 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.8 | 14.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.8 | 2.4 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.8 | 4.8 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.8 | 5.6 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.8 | 4.0 | GO:0045007 | depurination(GO:0045007) |
0.8 | 5.6 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.8 | 4.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.8 | 15.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.8 | 1.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.8 | 4.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.8 | 8.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.8 | 2.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.8 | 3.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.8 | 3.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.8 | 2.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.8 | 1.6 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.8 | 3.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.8 | 1.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.8 | 6.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.8 | 3.9 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.8 | 2.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.8 | 6.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.8 | 0.8 | GO:0015942 | formate metabolic process(GO:0015942) |
0.8 | 0.8 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.8 | 3.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.8 | 2.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.8 | 6.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.8 | 2.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.8 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.8 | 10.0 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 4.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 | 6.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 1.5 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.8 | 6.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.8 | 12.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.8 | 1.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.8 | 1.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.8 | 0.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.8 | 1.5 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.8 | 3.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.8 | 6.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.8 | 4.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.8 | 1.5 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.8 | 6.8 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 4.5 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.7 | 1.5 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.7 | 3.7 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.7 | 13.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.7 | 3.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.7 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 4.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 5.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.7 | 3.7 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.7 | 19.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.7 | 0.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.7 | 0.7 | GO:0043380 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
0.7 | 2.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.7 | 0.7 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) protein localization to nucleoplasm(GO:1990173) |
0.7 | 4.4 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.7 | 6.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.7 | 1.5 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 5.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.7 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.7 | 2.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.7 | 5.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 2.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.7 | 5.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.7 | 7.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.7 | 2.2 | GO:0060032 | notochord regression(GO:0060032) |
0.7 | 3.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.7 | 18.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.7 | 2.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.7 | 25.9 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.7 | 2.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.7 | 4.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.7 | 5.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.7 | 2.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 2.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.7 | 5.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.7 | 3.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.7 | 2.9 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.7 | 2.1 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.7 | 5.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.7 | 2.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.7 | 5.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 14.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.7 | 5.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.7 | 2.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.7 | 2.1 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.7 | 2.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.7 | 19.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.7 | 16.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.7 | 7.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.7 | 6.3 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.7 | 1.4 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.7 | 4.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.7 | 10.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.7 | 25.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.7 | 2.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.7 | 1.4 | GO:0032632 | interleukin-3 production(GO:0032632) divalent metal ion export(GO:0070839) |
0.7 | 4.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.7 | 2.1 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.7 | 2.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.7 | 1.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.7 | 4.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.7 | 0.7 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.7 | 0.7 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
0.7 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.7 | 2.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.7 | 23.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.7 | 1.4 | GO:0043335 | protein unfolding(GO:0043335) |
0.7 | 0.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.7 | 1.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 8.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 2.7 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.7 | 3.4 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.7 | 0.7 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.7 | 2.7 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.7 | 0.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.7 | 0.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.7 | 8.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.7 | 7.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.7 | 11.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.7 | 3.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.7 | 0.7 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.7 | 4.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.7 | 7.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.7 | 1.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.7 | 2.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.7 | 3.9 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.7 | 5.9 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.7 | 3.9 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.7 | 5.9 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.7 | 2.6 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.7 | 7.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.6 | 3.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.6 | 2.6 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
0.6 | 6.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.6 | 0.6 | GO:0034766 | negative regulation of ion transmembrane transport(GO:0034766) |
0.6 | 4.5 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 11.0 | GO:0015871 | choline transport(GO:0015871) |
0.6 | 0.6 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.6 | 1.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 13.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 1.9 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
0.6 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 2.5 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
0.6 | 5.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.6 | 12.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.6 | 8.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.6 | 4.4 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.6 | 6.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.6 | 2.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 1.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 1.9 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.6 | 3.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.6 | 0.6 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.6 | 0.6 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.6 | 1.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 1.2 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.6 | 3.7 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.6 | 4.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 2.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.6 | 28.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.6 | 1.9 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.6 | 14.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.6 | 1.9 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.6 | 7.4 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.6 | 8.0 | GO:0060022 | hard palate development(GO:0060022) |
0.6 | 1.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.6 | 8.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.6 | 2.5 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.6 | 3.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.6 | 63.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.6 | 14.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 2.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 1.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.6 | 2.4 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.6 | 2.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.6 | 3.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.6 | 3.7 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.6 | 3.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 2.4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.6 | 6.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.6 | 7.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.6 | 3.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.6 | 38.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 13.2 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.6 | 2.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.6 | 1.8 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.6 | 3.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.6 | 0.6 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.6 | 3.0 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.6 | 4.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 5.4 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.6 | 2.4 | GO:0007620 | copulation(GO:0007620) |
0.6 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.6 | 1.8 | GO:0044805 | late nucleophagy(GO:0044805) |
0.6 | 1.8 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.6 | 3.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.6 | 3.0 | GO:0035624 | receptor transactivation(GO:0035624) |
0.6 | 4.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.6 | 2.4 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.6 | 0.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.6 | 7.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.6 | 1.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.6 | 11.7 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.6 | 2.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.6 | 1.7 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
0.6 | 2.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.6 | 4.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 6.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.6 | 4.6 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 4.0 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.6 | 1.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.6 | 0.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.6 | 2.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.6 | 2.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.6 | 2.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 2.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.6 | 20.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.6 | 2.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 1.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.6 | 13.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.6 | 1.7 | GO:0021503 | neural fold bending(GO:0021503) |
0.6 | 3.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 1.1 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.6 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 4.5 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.6 | 1.1 | GO:0035280 | positive regulation of Schwann cell differentiation(GO:0014040) miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.6 | 9.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.6 | 2.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 6.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 2.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.6 | 1.7 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.6 | 3.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.6 | 0.6 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.6 | 3.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.5 | 1.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 1.6 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.5 | 9.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 0.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.5 | 11.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.5 | 4.4 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.5 | 1.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.5 | 1.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) negative regulation of fibroblast growth factor production(GO:0090272) |
0.5 | 2.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 1.6 | GO:2001112 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.5 | 4.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.5 | 2.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 3.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 3.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.5 | 14.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.5 | 1.6 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
0.5 | 5.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.5 | 0.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 2.2 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.5 | 6.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.5 | 0.5 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.5 | 5.4 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 | 1.1 | GO:0019860 | uracil metabolic process(GO:0019860) |
0.5 | 5.4 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
0.5 | 2.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 0.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.5 | 5.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 19.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.5 | 2.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.5 | 1.6 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.5 | 1.6 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.5 | 4.8 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.5 | 2.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 5.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 1.1 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.5 | 4.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 17.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 10.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 4.8 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.5 | 11.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 2.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.5 | 2.6 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.5 | 1.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.5 | 2.6 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.5 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 1.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.5 | 1.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.5 | 0.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 1.6 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.5 | 8.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 0.5 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
0.5 | 6.8 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.5 | 8.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 3.6 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.5 | 1.6 | GO:0002384 | hepatic immune response(GO:0002384) |
0.5 | 3.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 10.4 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.5 | 6.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.5 | 10.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.5 | 2.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.5 | 7.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.5 | 3.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.5 | 2.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.5 | 2.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 18.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 3.1 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.5 | 1.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 2.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.5 | 2.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.5 | 2.0 | GO:0090034 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.5 | 1.0 | GO:0072338 | cellular lactam metabolic process(GO:0072338) |
0.5 | 2.0 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.5 | 1.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 | 0.5 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
0.5 | 1.5 | GO:0060992 | response to fungicide(GO:0060992) |
0.5 | 2.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.5 | 9.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 2.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.5 | 2.0 | GO:0051413 | response to cortisone(GO:0051413) |
0.5 | 2.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 2.0 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.5 | 1.0 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.5 | 1.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 5.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 9.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.5 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.5 | 4.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 6.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.5 | 1.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 57.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.5 | 4.9 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.5 | 10.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 1.9 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.5 | 4.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 2.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.5 | 4.4 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.5 | 1.9 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.5 | 4.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 2.9 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.5 | 1.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 7.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 5.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.5 | 5.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 2.9 | GO:0061470 | macrophage colony-stimulating factor production(GO:0036301) T follicular helper cell differentiation(GO:0061470) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.5 | 1.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 1.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 1.4 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.5 | 1.9 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.5 | 70.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 7.6 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.5 | 4.7 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.5 | 2.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.5 | 1.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 2.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.5 | 0.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 0.5 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.5 | 2.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.5 | 1.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.5 | 4.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 8.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.5 | 4.7 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) |
0.5 | 8.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.5 | 2.8 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.5 | 1.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.5 | 1.4 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.5 | 1.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.5 | 0.9 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.5 | 1.9 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.5 | 0.5 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.5 | 3.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 1.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.5 | 5.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.5 | 0.5 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.5 | 1.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 1.4 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.5 | 15.5 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.5 | 7.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.5 | 1.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.5 | 1.4 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.5 | 9.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 2.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.5 | 0.9 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 0.5 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.5 | 1.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.5 | 0.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 3.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 0.9 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.5 | 0.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.5 | 15.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 14.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.5 | 3.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.4 | 2.2 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.4 | 2.2 | GO:0071649 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.4 | 1.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.4 | 3.6 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.4 | 5.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.4 | 2.2 | GO:0042100 | B cell proliferation(GO:0042100) |
0.4 | 8.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.4 | 5.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 2.7 | GO:0030421 | defecation(GO:0030421) |
0.4 | 2.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 8.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 9.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.4 | 2.2 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.4 | 1.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) AMP salvage(GO:0044209) |
0.4 | 2.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.4 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 0.9 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.4 | 1.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 0.9 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.4 | 11.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 2.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.4 | 3.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 2.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.4 | 3.9 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.4 | 12.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.4 | 6.9 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.4 | 5.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 0.9 | GO:0009644 | response to high light intensity(GO:0009644) |
0.4 | 1.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.4 | 0.9 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 3.9 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.4 | 2.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 11.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 0.8 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.4 | 1.3 | GO:0071529 | cementum mineralization(GO:0071529) |
0.4 | 3.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 0.8 | GO:0009624 | response to nematode(GO:0009624) |
0.4 | 20.2 | GO:1901998 | toxin transport(GO:1901998) |
0.4 | 0.4 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.4 | 0.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.4 | 5.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.4 | 8.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 9.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.4 | 1.3 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
0.4 | 2.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.4 | 6.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.4 | 0.4 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.4 | 1.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 5.8 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 0.8 | GO:0036292 | DNA rewinding(GO:0036292) |
0.4 | 0.8 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.4 | 2.1 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.4 | 3.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.4 | 3.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 1.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.4 | 1.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.4 | 1.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.4 | 1.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 4.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.4 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 4.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.4 | 11.5 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.4 | 4.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 5.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.4 | 0.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 3.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 0.8 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 3.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 0.8 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.4 | 254.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.4 | 8.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 0.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.4 | 1.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 3.6 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 37.8 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 1.6 | GO:0034699 | response to luteinizing hormone(GO:0034699) |
0.4 | 10.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.4 | 0.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.4 | 2.0 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.4 | 11.5 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.4 | 1.2 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.4 | 0.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.4 | 2.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 0.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.4 | 7.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 0.8 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) phosphatidylglycerol metabolic process(GO:0046471) |
0.4 | 0.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.4 | 0.4 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.4 | 10.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 1.9 | GO:0006311 | meiotic gene conversion(GO:0006311) |
0.4 | 1.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.2 | GO:0061643 | chemorepulsion of branchiomotor axon(GO:0021793) chemorepulsion of axon(GO:0061643) |
0.4 | 0.4 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.4 | 0.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.4 | 1.5 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.4 | 1.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 3.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 2.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.4 | 9.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 2.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.4 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 1.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 0.4 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.4 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.4 | 3.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.4 | 2.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.1 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.4 | 1.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.4 | 2.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 5.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.4 | 1.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.5 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
0.4 | 17.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 4.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.4 | 1.5 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.4 | 1.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 2.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 4.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 1.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.4 | 3.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.4 | 3.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 2.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 2.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.4 | 3.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.4 | 2.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 1.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.4 | 0.4 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.4 | 6.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 1.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 3.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.4 | 1.1 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.4 | 0.4 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.4 | 1.4 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.4 | 2.9 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.4 | 2.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.4 | 0.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.4 | 0.7 | GO:0046495 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.4 | 5.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 1.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.4 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.4 | 0.7 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.4 | 1.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 0.7 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.4 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 1.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.4 | 33.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.4 | 0.7 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.4 | 3.9 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.4 | 2.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 0.7 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.3 | 1.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 3.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 1.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 57.6 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.3 | 9.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 4.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 0.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 40.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 2.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.3 | 2.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.3 | 2.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 13.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 0.7 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.3 | 16.1 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.3 | 4.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 3.8 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.3 | 2.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.3 | 0.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.3 | 5.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 2.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.3 | 0.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 1.0 | GO:2000078 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
0.3 | 3.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 20.8 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.3 | 4.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 5.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 19.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 3.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.3 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.3 | 1.0 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.3 | 5.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 2.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 3.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 4.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 4.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 2.0 | GO:0018032 | protein amidation(GO:0018032) |
0.3 | 3.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.3 | 1.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 11.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 4.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.3 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.3 | 2.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 4.2 | GO:0060065 | uterus development(GO:0060065) |
0.3 | 0.3 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.3 | 0.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 2.5 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.3 | 0.9 | GO:0051253 | negative regulation of RNA metabolic process(GO:0051253) |
0.3 | 4.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 2.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.6 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.3 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 1.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 5.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.3 | 0.9 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.3 | 0.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 1.5 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.3 | 1.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 10.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.3 | 0.9 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 3.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.6 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 1.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.3 | 3.0 | GO:0097435 | fibril organization(GO:0097435) |
0.3 | 1.2 | GO:0035878 | nail development(GO:0035878) |
0.3 | 2.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.6 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.3 | 13.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.3 | 1.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 0.6 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 15.0 | GO:0031295 | T cell costimulation(GO:0031295) |
0.3 | 9.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.3 | 0.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 4.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 2.1 | GO:0032329 | serine transport(GO:0032329) |
0.3 | 18.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.3 | 24.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 0.6 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.3 | 0.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 4.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 1.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.3 | 1.5 | GO:0042092 | type 2 immune response(GO:0042092) |
0.3 | 1.2 | GO:0010157 | response to chlorate(GO:0010157) |
0.3 | 0.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.3 | 9.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 2.3 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 2.3 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.3 | 2.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 5.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.3 | 2.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 0.6 | GO:0048538 | thymus development(GO:0048538) |
0.3 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.9 | GO:0032196 | transposition(GO:0032196) |
0.3 | 1.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.3 | 2.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 2.9 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.3 | 0.9 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.3 | 1.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.3 | 1.7 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.3 | 0.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.6 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.3 | 23.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 2.3 | GO:0015811 | L-cystine transport(GO:0015811) |
0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.3 | 6.6 | GO:0016573 | histone acetylation(GO:0016573) |
0.3 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.3 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 0.9 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 1.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.3 | 1.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.3 | 3.4 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.3 | 2.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 9.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 2.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 1.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.3 | 3.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 0.8 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.3 | 3.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 10.9 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.3 | 1.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 3.3 | GO:0090656 | t-circle formation(GO:0090656) |
0.3 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 1.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.3 | 0.8 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.3 | 3.0 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.3 | 0.5 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.3 | 1.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 0.8 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) polynucleotide 5' dephosphorylation(GO:0098507) |
0.3 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 1.9 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 3.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 3.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 8.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.3 | 2.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.3 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.3 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 1.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 3.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.3 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.3 | 1.1 | GO:0071317 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.3 | 3.8 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 0.5 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.3 | 0.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 1.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.3 | 1.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 6.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 6.7 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.3 | 0.5 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.3 | 2.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 7.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.3 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 | 0.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 2.6 | GO:0000732 | strand displacement(GO:0000732) |
0.3 | 0.3 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.3 | 2.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 3.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 2.6 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 0.3 | GO:2000646 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 0.3 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.3 | 2.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 0.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.3 | 1.0 | GO:0018277 | protein deamination(GO:0018277) |
0.3 | 0.8 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.3 | 1.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 2.3 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.3 | 0.5 | GO:2000822 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 5.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.8 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 1.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 1.0 | GO:0044211 | CTP salvage(GO:0044211) |
0.3 | 1.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 0.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 0.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 1.8 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.3 | 0.3 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.3 | 0.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.3 | 1.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 4.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 1.7 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 8.9 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.2 | 3.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 0.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 17.8 | GO:0030217 | T cell differentiation(GO:0030217) |
0.2 | 1.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 2.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 6.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 2.7 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.2 | 1.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 2.0 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 0.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 1.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 1.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 2.9 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.2 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) developmental pigmentation(GO:0048066) pigment cell differentiation(GO:0050931) |
0.2 | 6.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 14.9 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 1.0 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.2 | 1.4 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.2 | 1.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 2.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 1.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 1.0 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.2 | 0.7 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 0.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 2.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 15.1 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 2.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 4.7 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.2 | 1.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 1.9 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 17.8 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 3.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 8.8 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.2 | 1.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 1.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 6.4 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.2 | 0.7 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.2 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.9 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.2 | 1.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.5 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.2 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
0.2 | 7.2 | GO:0051303 | establishment of chromosome localization(GO:0051303) |
0.2 | 0.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 2.5 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.2 | 6.9 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 1.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 1.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 1.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 1.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.2 | 1.3 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.2 | 0.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.2 | 1.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 1.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.2 | 1.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.2 | 1.1 | GO:0044208 | AMP biosynthetic process(GO:0006167) 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 7.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 0.4 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 4.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 12.6 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.2 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 2.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 1.7 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.2 | 0.6 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 5.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 2.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 1.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 22.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.4 | GO:0060488 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 3.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.2 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.0 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.2 | 1.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.2 | 1.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 1.0 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.2 | 1.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.8 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.2 | 1.0 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
0.2 | 2.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 4.6 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.2 | 4.6 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 2.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.2 | 1.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.2 | 0.2 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 0.8 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.2 | 1.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.2 | 1.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.2 | 0.2 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.2 | 3.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 2.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 1.3 | GO:0032613 | interleukin-10 production(GO:0032613) regulation of interleukin-10 production(GO:0032653) |
0.2 | 3.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 1.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.2 | 0.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.9 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 1.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 1.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.1 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 0.6 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.2 | 0.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 3.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 1.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.2 | 3.1 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
0.2 | 6.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 0.4 | GO:1901992 | positive regulation of mitotic cell cycle phase transition(GO:1901992) |
0.2 | 1.3 | GO:0031098 | stress-activated protein kinase signaling cascade(GO:0031098) |
0.2 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.2 | 0.7 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 3.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 3.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 0.4 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.2 | 2.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 1.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.2 | 0.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.7 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 1.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 0.2 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
0.2 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 5.2 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 1.7 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 3.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 39.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 3.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.9 | GO:0097384 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular lipid biosynthetic process(GO:0097384) |
0.2 | 0.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.2 | 3.1 | GO:1902275 | regulation of chromatin organization(GO:1902275) |
0.2 | 7.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 2.4 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.5 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.2 | 3.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.2 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.2 | 0.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.2 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.2 | 0.8 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 4.6 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 4.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.3 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 1.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.2 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.2 | 2.0 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.2 | 1.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 1.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 4.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.3 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
0.2 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 2.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 0.8 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.2 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.3 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.6 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.2 | 0.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.3 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 2.2 | GO:0001502 | cartilage condensation(GO:0001502) |
0.2 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.9 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.2 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 4.9 | GO:0007254 | JNK cascade(GO:0007254) |
0.2 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.8 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.2 | 0.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.2 | 0.6 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.9 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 4.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.4 | GO:0072007 | mesangial cell differentiation(GO:0072007) mesangial cell development(GO:0072143) |
0.1 | 1.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 5.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 3.3 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 3.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 1.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 2.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.6 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 2.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 4.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.7 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 0.5 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 4.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 3.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 2.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 4.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 1.5 | GO:0075733 | intracellular transport of virus(GO:0075733) |
0.1 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 0.5 | GO:0006007 | glucose catabolic process(GO:0006007) NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 1.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 2.8 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 0.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.2 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 5.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.5 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 1.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 1.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.7 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 8.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 14.0 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.1 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.1 | 72.8 | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.9 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 1.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 2.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 2.2 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.2 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.1 | 0.8 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.1 | 2.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.8 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.1 | 0.6 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.6 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.5 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.2 | GO:0014857 | skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.2 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.4 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.3 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.1 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.3 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 0.7 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.1 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.1 | 0.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.3 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.1 | 0.7 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.1 | 0.4 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.1 | 0.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.1 | 0.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 2.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
0.1 | 5.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 1.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.5 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 1.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 1.4 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 0.3 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 0.1 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.1 | 1.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 1.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 1.4 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.1 | 0.3 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.1 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.7 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.1 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.1 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.3 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 3.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 1.1 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.1 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.1 | 0.7 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.4 | GO:0036296 | response to increased oxygen levels(GO:0036296) |
0.1 | 0.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.1 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.3 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0070302 | regulation of stress-activated protein kinase signaling cascade(GO:0070302) |
0.1 | 0.2 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.1 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 0.4 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.1 | 0.6 | GO:0015827 | tryptophan transport(GO:0015827) |
0.1 | 0.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 3.3 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 0.6 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 1.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0090672 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.1 | 0.1 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.4 | GO:0071389 | cellular response to mineralocorticoid stimulus(GO:0071389) |
0.1 | 0.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 7.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.7 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 3.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.8 | GO:0000725 | recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0070781 | response to biotin(GO:0070781) |
0.1 | 0.4 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.1 | 3.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.1 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.1 | 0.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.4 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.1 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.1 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.6 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.1 | 0.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 1.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.0 | 0.5 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.0 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 1.4 | GO:0021532 | neural tube patterning(GO:0021532) |
0.0 | 0.6 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0032655 | regulation of interleukin-12 production(GO:0032655) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 2.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 1.5 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.0 | 1.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 1.9 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.0 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.1 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.0 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.0 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.3 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.0 | 0.0 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.1 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.4 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.5 | GO:0098751 | bone cell development(GO:0098751) |
0.0 | 0.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 | 0.1 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.0 | 0.0 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 2.1 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.6 | GO:0043574 | peroxisomal transport(GO:0043574) |
0.0 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 2.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.4 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.2 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 1.4 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 1.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 2.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.2 | GO:0060323 | head morphogenesis(GO:0060323) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.7 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.1 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.0 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.4 | GO:0050727 | regulation of inflammatory response(GO:0050727) |
0.0 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 4.3 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.2 | GO:0007292 | female gamete generation(GO:0007292) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 19.8 | GO:0031523 | Myb complex(GO:0031523) |
4.6 | 13.7 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
3.8 | 15.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
2.8 | 8.4 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
2.7 | 10.9 | GO:0043293 | apoptosome(GO:0043293) |
2.7 | 8.2 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
2.6 | 10.5 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
2.2 | 17.7 | GO:0070876 | SOSS complex(GO:0070876) |
2.0 | 9.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.9 | 11.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
1.8 | 5.5 | GO:0008623 | CHRAC(GO:0008623) |
1.7 | 5.2 | GO:0036398 | TCR signalosome(GO:0036398) |
1.7 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
1.7 | 13.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
1.6 | 11.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.6 | 8.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.6 | 4.8 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
1.6 | 4.8 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
1.6 | 28.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.6 | 11.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.5 | 6.1 | GO:0045160 | myosin I complex(GO:0045160) |
1.5 | 29.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.5 | 12.2 | GO:0001740 | Barr body(GO:0001740) |
1.5 | 9.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
1.5 | 7.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.5 | 11.6 | GO:0071203 | WASH complex(GO:0071203) |
1.4 | 11.2 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
1.4 | 7.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.4 | 6.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.3 | 5.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.3 | 12.0 | GO:0044194 | cytolytic granule(GO:0044194) |
1.3 | 1.3 | GO:0000805 | X chromosome(GO:0000805) Y chromosome(GO:0000806) |
1.3 | 12.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.3 | 7.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.2 | 5.0 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
1.2 | 15.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.2 | 8.1 | GO:0042825 | TAP complex(GO:0042825) |
1.1 | 8.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.1 | 3.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
1.1 | 31.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 3.4 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
1.1 | 3.4 | GO:0075341 | host cell PML body(GO:0075341) |
1.1 | 11.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.1 | 14.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 3.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.1 | 19.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.1 | 2.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.1 | 6.4 | GO:0032010 | phagolysosome(GO:0032010) |
1.1 | 25.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.0 | 8.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.0 | 11.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.0 | 5.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
1.0 | 4.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.0 | 2.9 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
1.0 | 2.9 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
1.0 | 9.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.9 | 10.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.9 | 11.3 | GO:0072487 | MSL complex(GO:0072487) |
0.9 | 10.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.9 | 1.9 | GO:1990923 | PET complex(GO:1990923) |
0.9 | 1.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.9 | 3.7 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.9 | 6.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.9 | 3.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 3.7 | GO:0032449 | CBM complex(GO:0032449) |
0.9 | 6.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 10.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.9 | 3.5 | GO:0044753 | amphisome(GO:0044753) |
0.9 | 4.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.8 | 2.5 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.8 | 6.7 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 42.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.8 | 3.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.8 | 10.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.8 | 5.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 9.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.8 | 6.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.8 | 13.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.8 | 7.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 4.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 3.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.8 | 3.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 4.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.8 | 13.7 | GO:0090543 | Flemming body(GO:0090543) |
0.8 | 2.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.8 | 1.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.7 | 4.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.7 | 2.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.7 | 2.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.7 | 4.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.7 | 115.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 5.0 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.7 | 2.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.7 | 18.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 1.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.7 | 2.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.7 | 90.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.7 | 9.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.7 | 18.5 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 15.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 8.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 2.7 | GO:0031905 | early endosome lumen(GO:0031905) |
0.7 | 57.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.7 | 6.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 74.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.7 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 6.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.7 | 7.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 22.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 10.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.6 | 3.2 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.6 | 49.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.6 | 9.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.6 | 3.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 1.9 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.6 | 8.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.6 | 0.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.6 | 6.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 4.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 4.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 4.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.6 | 54.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.6 | 2.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 1.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.6 | 18.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 5.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 15.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.6 | 1.8 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.6 | 3.5 | GO:0032021 | NELF complex(GO:0032021) |
0.6 | 6.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.6 | 3.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.6 | 19.8 | GO:0031105 | septin complex(GO:0031105) |
0.6 | 8.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.6 | 99.8 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.6 | 13.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.6 | 2.2 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.6 | 5.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 4.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.5 | 1.6 | GO:0035101 | FACT complex(GO:0035101) |
0.5 | 2.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 2.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 10.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 7.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 1.1 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.5 | 11.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 2.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.5 | 218.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.5 | 89.1 | GO:0016605 | PML body(GO:0016605) |
0.5 | 2.6 | GO:0002133 | polycystin complex(GO:0002133) |
0.5 | 1.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 6.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 2.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.5 | 3.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 6.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 4.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 24.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 2.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.5 | 27.7 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 26.1 | GO:0002102 | podosome(GO:0002102) |
0.5 | 2.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 3.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.5 | 1.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.5 | 3.8 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 1.9 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.5 | 6.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 2.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.5 | 5.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 1.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 1.8 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.4 | 59.3 | GO:0035579 | specific granule membrane(GO:0035579) |
0.4 | 3.1 | GO:0001652 | granular component(GO:0001652) |
0.4 | 1.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 2.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 5.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 1.3 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.4 | 34.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 49.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 1.7 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.4 | 4.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 9.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 0.4 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.4 | 2.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 11.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 2.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.4 | 8.4 | GO:0042611 | MHC protein complex(GO:0042611) |
0.4 | 0.8 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.4 | 4.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 4.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 4.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 3.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 6.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 2.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 3.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 11.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 4.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 4.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 4.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 8.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 5.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 3.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 5.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 1.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 2.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 3.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 1.8 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 11.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 2.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 2.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.3 | 1.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.3 | 6.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 7.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 1.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 7.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 6.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.3 | 1.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 0.7 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.3 | 0.7 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 25.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 3.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 3.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.0 | GO:0031213 | RSF complex(GO:0031213) |
0.3 | 5.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 7.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 23.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 1.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 0.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.5 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.3 | 3.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 4.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 1.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 4.9 | GO:0032059 | bleb(GO:0032059) |
0.3 | 2.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 3.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 4.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 8.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 2.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 6.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 7.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 5.9 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.3 | 4.4 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 2.9 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.3 | 1.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 2.0 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 2.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 3.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.3 | 1.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 0.8 | GO:0034455 | t-UTP complex(GO:0034455) |
0.3 | 2.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 1.1 | GO:0097196 | Shu complex(GO:0097196) |
0.3 | 6.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 4.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 2.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 0.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.3 | 2.1 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 8.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.3 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 2.6 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 1.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 2.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 0.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.3 | 0.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.3 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 1.8 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 12.5 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 5.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 206.5 | GO:0016604 | nuclear body(GO:0016604) |
0.3 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 1.0 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 2.7 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 2.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 1.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 5.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 12.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 26.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 5.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 2.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 1.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 3.8 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 0.9 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 1.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 1.2 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 22.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 3.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 8.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 2.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 21.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 33.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 23.4 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 2.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 2.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 5.2 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 14.4 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.2 | 0.9 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.2 | 1.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.2 | 6.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 5.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 127.4 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 3.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 0.6 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 2.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 0.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 13.4 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 4.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 28.1 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 2.0 | GO:0030496 | midbody(GO:0030496) |
0.2 | 5.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 2.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 5.1 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.2 | 5.1 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 2.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 15.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 4.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 34.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 2.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 35.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 475.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 7.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 3.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.2 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 3.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 4.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.4 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 1.0 | GO:0030677 | ribonuclease P complex(GO:0030677) mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 10.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.1 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) |
0.1 | 1.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 2.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 29.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 9.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 7.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 4.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.0 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 20.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 8.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 4.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 3.5 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.1 | 44.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 7.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 7.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.4 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 3.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.8 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 5.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.0 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.0 | 1.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 91.3 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.9 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
3.4 | 17.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
3.4 | 34.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
3.4 | 20.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.3 | 23.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
3.0 | 21.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.9 | 8.6 | GO:0030395 | lactose binding(GO:0030395) |
2.5 | 7.6 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
2.5 | 9.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.4 | 11.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.3 | 7.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
2.3 | 6.8 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
2.3 | 9.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
2.2 | 20.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
2.2 | 6.6 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
2.1 | 10.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
2.1 | 12.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
2.0 | 5.9 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
1.9 | 17.4 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.9 | 9.6 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
1.9 | 7.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
1.9 | 9.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.9 | 9.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.9 | 24.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.8 | 5.5 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
1.8 | 7.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.8 | 1.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.8 | 3.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.8 | 7.1 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.8 | 8.8 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
1.8 | 19.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
1.7 | 5.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.7 | 5.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.7 | 8.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.7 | 5.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.7 | 5.0 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.6 | 11.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.6 | 6.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
1.6 | 14.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.6 | 6.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.6 | 4.8 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
1.6 | 9.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.6 | 4.7 | GO:0070984 | SET domain binding(GO:0070984) |
1.5 | 3.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
1.5 | 1.5 | GO:0043274 | phospholipase binding(GO:0043274) |
1.5 | 10.5 | GO:0046979 | TAP2 binding(GO:0046979) |
1.5 | 6.0 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
1.4 | 7.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
1.4 | 7.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.4 | 8.6 | GO:0039552 | RIG-I binding(GO:0039552) |
1.4 | 7.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
1.4 | 2.8 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
1.4 | 2.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.4 | 4.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.4 | 5.6 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
1.4 | 28.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.4 | 4.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
1.3 | 5.4 | GO:0032427 | GBD domain binding(GO:0032427) |
1.3 | 9.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.3 | 4.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.3 | 19.5 | GO:0019826 | oxygen sensor activity(GO:0019826) |
1.3 | 5.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.3 | 5.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
1.3 | 5.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
1.3 | 17.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.3 | 11.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.3 | 7.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.3 | 5.0 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
1.2 | 4.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.2 | 2.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
1.2 | 9.8 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
1.2 | 7.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.2 | 3.7 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
1.2 | 3.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.2 | 8.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
1.2 | 8.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.2 | 9.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 40.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.2 | 3.5 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
1.2 | 3.5 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
1.2 | 4.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
1.2 | 4.6 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
1.1 | 5.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.1 | 4.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
1.1 | 3.4 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
1.1 | 1.1 | GO:0048030 | disaccharide binding(GO:0048030) |
1.1 | 14.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.1 | 4.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.1 | 23.5 | GO:0003680 | AT DNA binding(GO:0003680) |
1.1 | 3.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
1.0 | 3.1 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
1.0 | 1.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
1.0 | 7.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.0 | 15.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.0 | 1.0 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
1.0 | 9.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.0 | 7.1 | GO:0043426 | MRF binding(GO:0043426) |
1.0 | 1.0 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
1.0 | 4.0 | GO:0034046 | poly(G) binding(GO:0034046) |
1.0 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.0 | 3.0 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
1.0 | 7.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.0 | 4.9 | GO:0034584 | piRNA binding(GO:0034584) |
1.0 | 16.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.0 | 7.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.0 | 3.9 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
1.0 | 5.9 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.0 | 21.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 2.9 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
1.0 | 56.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.0 | 2.9 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
1.0 | 3.8 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
1.0 | 18.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.0 | 8.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.0 | 14.3 | GO:0050700 | CARD domain binding(GO:0050700) |
1.0 | 41.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.9 | 2.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.9 | 11.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.9 | 9.3 | GO:0019863 | IgE binding(GO:0019863) |
0.9 | 11.1 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.9 | 18.5 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 7.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 2.7 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.9 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.9 | 2.7 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.9 | 7.8 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.9 | 2.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.9 | 7.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.9 | 6.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.9 | 6.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 4.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.8 | 17.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 8.5 | GO:0005497 | androgen binding(GO:0005497) |
0.8 | 22.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 3.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.8 | 5.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.8 | 3.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.8 | 5.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.8 | 2.5 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.8 | 3.4 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.8 | 4.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 2.5 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.8 | 20.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 5.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 2.5 | GO:0097689 | iron channel activity(GO:0097689) |
0.8 | 5.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 11.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 4.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 18.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 0.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.8 | 3.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.8 | 2.3 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.8 | 5.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.8 | 7.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.8 | 2.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.8 | 3.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.8 | 10.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.8 | 3.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.8 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
0.8 | 6.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.8 | 2.3 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.8 | 8.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 3.0 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.8 | 3.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.7 | 4.5 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.7 | 1.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 16.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.7 | 7.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 19.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.7 | 2.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.7 | 28.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 0.7 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.7 | 35.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 14.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 6.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.7 | 8.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 5.1 | GO:0042806 | fucose binding(GO:0042806) |
0.7 | 4.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.7 | 2.9 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.7 | 0.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.7 | 1.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.7 | 12.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.7 | 7.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.7 | 2.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.7 | 5.0 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.7 | 0.7 | GO:0044388 | SUMO activating enzyme activity(GO:0019948) small protein activating enzyme binding(GO:0044388) |
0.7 | 2.8 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.7 | 3.5 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.7 | 24.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.7 | 9.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 10.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.7 | 2.1 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.7 | 3.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.7 | 0.7 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.7 | 2.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.7 | 2.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.7 | 4.8 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.7 | 2.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.7 | 2.0 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.7 | 19.6 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.7 | 7.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.7 | 2.7 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.7 | 18.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 4.0 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.7 | 7.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 9.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.7 | 29.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 2.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.6 | 27.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 2.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.6 | 7.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 3.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.6 | 7.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 24.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.6 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 5.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 81.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.6 | 20.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.6 | 4.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 1.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.6 | 3.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.6 | 2.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 1.9 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.6 | 5.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.6 | 2.5 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.6 | 9.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.6 | 14.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 3.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 1.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.6 | 10.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 8.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 5.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 3.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 9.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 1.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.6 | 6.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 4.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 3.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 1.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.6 | 10.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.6 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 4.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.6 | 7.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 2.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 2.4 | GO:0004803 | transposase activity(GO:0004803) |
0.6 | 0.6 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.6 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 2.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 1.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.6 | 2.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.6 | 1.7 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.6 | 1.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.6 | 27.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 111.6 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 1.7 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.6 | 2.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.6 | 1.7 | GO:0019955 | cytokine binding(GO:0019955) |
0.6 | 18.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.6 | 28.5 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.6 | 6.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 1.7 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.6 | 1.7 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.6 | 2.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.6 | 29.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.6 | 2.8 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.6 | 1.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.6 | 2.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 3.9 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.6 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.6 | 2.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.6 | 1.7 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.6 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 8.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 4.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 82.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 4.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 1.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.5 | 2.2 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.5 | 6.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 6.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 29.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.5 | 3.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 2.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 18.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.5 | 2.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.5 | 41.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 10.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 18.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.5 | 2.1 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.5 | 6.8 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.5 | 5.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 40.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 2.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.5 | 2.6 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.5 | 7.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 2.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.5 | 0.5 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.5 | 3.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 5.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.5 | 2.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.5 | 24.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.5 | 1.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.5 | 13.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.5 | 1.0 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.5 | 1.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.5 | 6.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 1.5 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.5 | 4.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.5 | 11.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 3.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.5 | 6.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 4.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 1.9 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.5 | 158.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.5 | 4.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.5 | 1.4 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.5 | 2.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 5.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.5 | 8.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 1.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.5 | 17.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 10.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 3.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.5 | 1.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.5 | 1.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 2.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.5 | 1.4 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.5 | 14.0 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 4.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 2.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.5 | 6.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 0.9 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.5 | 1.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.5 | 3.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 1.8 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.5 | 4.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 12.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 3.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 11.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 11.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.4 | 17.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 5.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.4 | 1.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 4.0 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 2.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 1.7 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.4 | 0.9 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 8.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.4 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 2.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 1.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.4 | 3.4 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 3.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 3.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 11.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 3.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 1.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.4 | 1.7 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.4 | 11.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 2.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 5.9 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 2.1 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.4 | 0.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 7.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 12.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.4 | 3.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 1.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.4 | 3.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 3.3 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 1.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.4 | 3.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.4 | 55.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 1.2 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.4 | 2.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 2.0 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.4 | 7.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.4 | 27.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.4 | 1.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 1.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 6.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 5.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 4.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 4.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 0.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.4 | 5.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 2.0 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.4 | 1.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 17.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 3.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 1.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.4 | 3.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 4.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 3.9 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.4 | 5.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 2.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 3.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 2.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.4 | 9.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 2.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 3.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.4 | 10.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 1.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 1.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.4 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 1.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.4 | 1.8 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 0.7 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.4 | 1.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 5.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 2.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.4 | 2.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.4 | 21.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 7.5 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 1.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.4 | 1.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.4 | 2.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 1.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 6.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 1.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 0.3 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
0.3 | 6.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 7.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 30.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 1.0 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.3 | 15.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 2.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 1.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 2.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 6.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.0 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.3 | 5.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 6.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 9.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 1.0 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.3 | 1.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 16.6 | GO:0000975 | regulatory region DNA binding(GO:0000975) |
0.3 | 2.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 8.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 5.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 6.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 3.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.0 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.3 | 13.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 77.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 1.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.3 | 2.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.3 | 18.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 4.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.3 | 8.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.3 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 9.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 1.3 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.3 | 1.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 3.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 62.3 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 2.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.6 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.3 | 1.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 4.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 5.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 19.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 2.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.9 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.3 | 4.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 1.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.3 | 13.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 3.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 21.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 8.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 3.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 12.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 7.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 14.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.2 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.3 | 2.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 1.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 3.0 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.3 | 0.9 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.3 | 1.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.3 | 1.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 2.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 75.9 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.3 | 2.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.3 | 1.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.3 | 0.9 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.3 | 2.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 3.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 2.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.3 | 0.3 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 1.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 1.7 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 70.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 2.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 5.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 2.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 2.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 19.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 0.9 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.3 | 1.4 | GO:0035326 | enhancer binding(GO:0035326) |
0.3 | 4.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 6.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 3.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 0.6 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.3 | 0.8 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.3 | 10.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 1.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.3 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 5.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 3.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 4.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.3 | 0.5 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.3 | 1.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 1.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 0.8 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.3 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 0.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.3 | 2.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 2.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 6.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 12.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 1.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.8 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 9.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 7.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 6.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 3.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 8.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 1.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.3 | 0.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 1.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.2 | 3.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 40.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 32.1 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.7 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 7.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 1.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.2 | 2.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 92.3 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.2 | 1.9 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 2.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 13.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 1.7 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.2 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 2.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.2 | 8.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.4 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.2 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.9 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 6.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.2 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 0.7 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.2 | 2.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 50.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 5.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 6.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 20.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 0.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.2 | 0.7 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 0.7 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 5.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.2 | 10.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.2 | 13.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 4.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 4.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.0 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 4.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.2 | 2.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 2.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 1.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 2.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 2.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.8 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.2 | 4.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 6.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.6 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 4.5 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 0.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.1 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 3.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 29.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 3.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 2.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 1.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 4.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 8.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.2 | 0.4 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.2 | 1.4 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 6.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 3.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.9 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 1.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 1.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 3.1 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.2 | 0.5 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.2 | 0.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 0.2 | GO:0032934 | sterol binding(GO:0032934) |
0.2 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 0.8 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 1.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 8.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.5 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 2.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.5 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.2 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.6 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.2 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 11.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.2 | 36.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 1.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.5 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.2 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 3.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.9 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 1.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 3.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 1.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 6.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 0.6 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 2.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 11.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 8.4 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.3 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.1 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 5.6 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 41.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 1.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 6.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 3.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 4.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 58.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 14.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.5 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 3.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 2.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 2.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 2.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 2.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.3 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.1 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 1.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 1.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 116.4 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.6 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.1 | 0.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.1 | 0.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.9 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.1 | 2.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 2.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 9.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0016882 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) cyclo-ligase activity(GO:0016882) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 1.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 2.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 2.5 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0052811 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.1 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 28.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 2.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
0.1 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.8 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.1 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.4 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.1 | 4.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.0 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 3.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 4.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 1.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 3.4 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.0 | 0.2 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.0 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.0 | 0.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 1.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.0 | 0.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.0 | 2.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.4 | 19.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.3 | 1.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
1.2 | 143.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.1 | 49.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.1 | 44.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.1 | 87.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.1 | 26.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.1 | 66.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.1 | 41.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 18.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.0 | 23.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.0 | 61.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.0 | 27.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.0 | 27.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 24.2 | PID EPO PATHWAY | EPO signaling pathway |
0.9 | 1.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.9 | 34.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.9 | 66.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.9 | 20.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.8 | 36.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.8 | 54.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 2.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.8 | 2.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.7 | 6.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 22.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 59.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 113.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.6 | 92.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.6 | 59.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 24.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 11.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 25.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 3.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.6 | 20.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 9.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 1.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 1.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 25.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 23.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.6 | 12.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 11.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 20.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 8.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.5 | 10.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 19.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 2.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 10.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 12.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 7.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 20.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 24.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 17.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 16.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 13.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 32.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 18.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 7.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 6.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 3.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 12.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 18.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 23.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 5.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 17.0 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 17.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.4 | 67.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 8.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 15.9 | PID ATM PATHWAY | ATM pathway |
0.3 | 10.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 11.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 5.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 24.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 6.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 31.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 1.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 3.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 3.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 11.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 4.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 5.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 12.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 10.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 4.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 3.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 3.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 9.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 3.2 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 8.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 6.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 5.0 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 0.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 5.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 19.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 4.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 1.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 12.9 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 13.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 5.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 7.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 5.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 1.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 8.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 10.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 10.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 2.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 4.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 5.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 38.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 8.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 3.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 3.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 3.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 3.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.7 | 1.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.5 | 4.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.5 | 17.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.4 | 1.4 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
1.4 | 2.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.4 | 8.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.3 | 13.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.3 | 1.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.2 | 33.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.2 | 76.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.1 | 59.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.1 | 4.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.1 | 44.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.0 | 28.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.0 | 12.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.9 | 7.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.9 | 16.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.9 | 6.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.9 | 28.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.9 | 19.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.9 | 46.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.9 | 6.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.9 | 3.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.9 | 1.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.8 | 4.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.8 | 32.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 14.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 28.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.8 | 41.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 7.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.8 | 5.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.8 | 31.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.8 | 12.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.7 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.7 | 46.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.7 | 30.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.7 | 9.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.7 | 17.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 9.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.6 | 8.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 8.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 19.5 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.6 | 6.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 16.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.6 | 8.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.6 | 27.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 9.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 4.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.6 | 16.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 12.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 11.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 1.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 21.8 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.6 | 7.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 26.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 43.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 24.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 14.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 5.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 5.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.5 | 83.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 11.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 14.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 19.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 8.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 1.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.5 | 11.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 12.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 8.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 37.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 2.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 5.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 16.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 1.3 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.4 | 35.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 0.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.4 | 0.4 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.4 | 20.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 12.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 8.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 9.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 16.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 5.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 17.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 10.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 3.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 55.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 7.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.4 | 24.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 38.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 19.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 10.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 5.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 25.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 5.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 4.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 5.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 44.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 8.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 4.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 34.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 36.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.3 | 8.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 8.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 15.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 5.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 3.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 5.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 10.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 2.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 9.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 7.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.3 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 20.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 39.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.3 | 9.0 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.3 | 6.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 7.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 5.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 18.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 3.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 3.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 61.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 0.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 2.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 1.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 2.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 7.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 3.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 2.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 41.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 35.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 13.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 4.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 6.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 6.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.2 | 0.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 4.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 4.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 4.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 5.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 2.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 3.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 5.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 2.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 14.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 1.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 1.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 8.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 18.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.2 | 9.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 4.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 1.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 1.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 3.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 3.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 2.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 3.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 8.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.9 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 3.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 2.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 5.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 2.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 4.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 5.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 2.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 3.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 2.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 2.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 1.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 5.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |